Preoperative Therapy for Extremity Soft Tissue Sarcomas
详细信息 查看全文
- 作者：Lara E. Davis M.D. ; Christopher W. Ryan M.D.
- 关键词：Neoadjuvant ; Preoperative ; Soft tissue sarcoma ; Chemoradiotherapy ; Chemotherapy ; Radiation
- 刊名：Current Treatment Options in Oncology
- 出版年：2015
- 出版时间：June 2015
- 年：2015
- 卷：16
- 期：6
- 全文大小：970 KB
- 参考文献：Papers of particular interest, published recently, have been highlighted as: 鈥?Of importance 鈥⑩€?Of major importance1.SEER Stat Fact Sheets: Soft tissue including heart cancer. [cited 2015 February 10]; Available from: http://鈥媠eer.鈥媍ancer.鈥媑ov/鈥媠tatfacts/鈥媓tml/鈥媠oft.鈥媓tml .
2.Suit HD, Russell WO, Martin RG. Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer. 1975;35(5):1478鈥?3.View Article PubMed
3.Lindberg RD et al. Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer. 1981;47(10):2391鈥?.View Article PubMed
4.Yang JC et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16(1):197鈥?03.PubMed
5.Rosenberg SA et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196(3):305鈥?5.View Article PubMed Central PubMed
6.Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997;350(9092):1647鈥?4.
7.Weitz J, Antonescu CR, Brennan MF. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol. 2003;21(14):2719鈥?5.View Article PubMed
8.鈥⑩€?/div>Woll PJ et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol. 2012;13(10):1045鈥?4. This multicenter randomized trial of adjuvant doxorubicin/ifosfamide for resected STS found no survival benefit but includes an updated meta-analysis suggesting that patients with large, high-grade extremity sarcomas are most likely to benefit from chemotherapy.View Article PubMed
9.Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults. Sarcoma Meta-analysis Collaboration (SMAC). Cochrane Database Syst Rev. 2000(2):CD001419.
10.Pervaiz N et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573鈥?1.View Article PubMed
11.O鈥橲ullivan B et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235鈥?1.View Article PubMed
12.Davis AM et al. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol. 2005;75(1):48鈥?3.View Article PubMed
13.Zagars GK et al. Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome. Int J Radiat Oncol Biol Phys. 2003;56(2):482鈥?.View Article PubMed
14.鈥⑩€?/div>Wang D, et al. Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of Radiation Therapy Oncology Group RTOG-0630 Trial. J Clin Oncol. 2015. doi:10.鈥?200/鈥婮CO.鈥?014.鈥?8.鈥?828 . This multicenter prospective phase II trial identified a significant reduction in late toxicities in patients with extremity STS treated with preoperative radiotherapy without an increased local recurrences.
15.Judson I, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15(4):415-423.
16.Antman KH et al. Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma. J Clin Oncol. 1989;7(1):126鈥?1.PubMed
17.O鈥橞ryan RM et al. Phase II evaluation of adriamycin in human neoplasia. Cancer. 1973;32(1):1鈥?.View Article PubMed
18.Bramwell VH et al. Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol. 1987;23(3):311鈥?1.View Article PubMed
19.Lorigan P et al. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. J Clin Oncol. 2007;25(21):3144鈥?0.View Article PubMed
20.Gortzak E et al. A randomised phase II study on neo-adjuvant chemotherapy for 鈥榟igh-risk鈥?adult soft-tissue sarcoma. Eur J Cancer. 2001;37(9):1096鈥?03.View Article PubMed
21.Grobmyer SR et al. Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol. 2004;15(11):1667鈥?2.View Article PubMed
22.Eilber FR et al. Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy. Cancer. 1984;53(12):2579鈥?4.View Article PubMed
23.Eilber F et al. Preoperative therapy for soft tissue sarcoma. Hematol Oncol Clin North Am. 1995;9(4):817鈥?3.PubMed
24.Edmonson JH et al. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor. Cancer. 2002;94(3):786鈥?2.View Article PubMed
25.DeLaney TF et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003;56(4):1117鈥?7.View Article PubMed
26.鈥⑩€?/div>Mullen JT et al. Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas. Cancer. 2012;118(15):3758鈥?5. With a median follow-up of over 9聽years, a single institution鈥檚 regimen of preoperative MAID chemotherapy with interdigitated radiation resulted favorable survival compared to historic controls.View Article PubMed
27.Pisters PW et al. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol. 2004;22(16):3375鈥?0.View Article PubMed
28.Mack L et al. Preoperative chemoradiotherapy (modified Eilber protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma. Ann Surg Oncol. 2005;12(8):646鈥?3.View Article PubMed
29.Ryan CW et al. Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas. Cancer. 2008;112(11):2432鈥?.View Article PubMed
30.Kraybill WG et al. Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall. Cancer. 2010;116(19):4613鈥?1.View Article PubMed Central PubMed
31.Hong NJL et al. Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study. Eur J Cancer. 2013;49(4):875鈥?3.View Article
32.鈥?/div>Meyer JM et al. Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates. Clin Cancer Res. 2013;19(24):6902鈥?1. The addition of sorafenib 400聽mg daily to a preoperative chemoradiation regimen was safe and effective, and DCE-MRI changes seen after 2聽weeks of therapy correlated with histopathologic response at time of surgery.View Article PubMed
33.Bedi M et al. Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy. Radiat Oncol. 2013;8(1):60.View Article PubMed Central PubMed
34.Raval RR, et al. Evaluating the role of interdigitated neoadjuvant chemotherapy and radiation in the management of high-grade soft-tissue sarcoma: the Johns Hopkins experience. Am J Clin Oncol. 2014.
35.Canter R et al. Phase I trial of neoadjuvant conformal radiotherapy plus Sorafenib for patients with locally advanced soft tissue sarcoma of the extremity. Ann Surg Oncol. 2014;21(5):1616鈥?3.View Article PubMed Central PubMed
36.Lewin J et al. A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma. Br J Cancer. 2014;111(12):2254鈥?1.View Article PubMed
37.Okuno SMD, et al. Chemotherapy, irradiation, and surgery for function-preserving curative therapy of primary extremity soft tissue sarcomas: initial treatment with I-MAP and inhalation GM-CSF during preoperative irradiation and postoperatively. Am J Clin Oncol. 2014.
38.Hoekstra HJ et al. A combination of intraarterial chemotherapy, preoperative and postoperative radiotherapy, and surgery as limb-saving treatment of primarily unresectable high-grade soft tissue sarcomas of the extremities. Cancer. 1989;63(1):59鈥?2.View Article PubMed
39.Goodnight Jr JE et al. Limb-sparing surgery for extremity sarcomas after preoperative intraarterial doxorubicin and radiation therapy. Am J Surg. 1985;150(1):109鈥?3.View Article PubMed
40.Denton JW et al. Preoperative regional chemotherapy and rapid-fraction irradiation for sarcomas of the soft tissue and bone. Surg Gynecol Obstet. 1984;158(6):545鈥?1.PubMed
41.Temple WJ et al. Neoadjuvant treatment in conservative surgery of peripheral sarcomas. Can J Surg. 1989;32(5):361鈥?.PubMed
42.Wanebo HJ et al. Preoperative regional therapy for extremity sarcoma. A tricenter update. Cancer. 1995;75(9):2299鈥?06.View Article PubMed
43.Levine EA, Trippon M, Das Gupta TK. Preoperative multimodality treatment for soft tissue sarcomas. Cancer. 1993;71(11):3685鈥?.View Article PubMed
44.Eilber FR et al. Intravenous (IV) vs. intraarterial (IA) Adriamycin, 2800r radiation and surgical excision for extremity soft tissue sarcomas: a randomized prospective trial. Proc Am Soc Clin Oncol. 1990;9:309a.
45.Frustaci S et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001;19(5):1238鈥?7.PubMed
46.Eilber FC et al. Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol. 2001;19(13):3203鈥?.PubMed
47.MacDermed DM et al. Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2010;76(4):1147鈥?3.View Article PubMed Central PubMed
48.Andreou D et al. Prognostic relevance of the mitotic count and the amount of viable tumour after neoadjuvant chemotherapy for primary, localised, high-grade soft tissue sarcoma. Br J Cancer. 2015;112(3):455鈥?0.View Article PubMed
49.Tateishi U et al. PET/CT allows stratification of responders to neoadjuvant chemotherapy for high-grade sarcoma: a prospective study. Clin Nucl Med. 2011;36(7):526鈥?2.View Article PubMed
50.Vaynrub M et al. Prognostic value of necrosis after neoadjuvant therapy for soft tissue sarcoma. J Surg Oncol. 2015;111(2):152鈥?.View Article PubMed
51.鈥?/div>Mullen JT et al. Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy. Cancer. 2014;120(23):3676鈥?2. Clinical outcomes for patients treated per single neoadjuvant chemoradiation protocol did not correlate with histopathologic response at time of surgery (鈮?5聽% necrosis).View Article PubMed
52.Radiation therapy with or without combination chemotherapy or pazopanib hydrochloride before surgery in treating patients with newly diagnosed non-rhabdomyosarcoma soft tissue sarcomas that can be removed by Surgery (PAZNTIS). [cited 2015 March 3]; Available from: https://鈥媍linicaltrials.鈥媑ov/鈥媍t2/鈥媠how/鈥婲CT02180867 .
53.Stacchiotti S et al. Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy. Cancer. 2012;118(23):5857鈥?6.View Article PubMed
54.Canter RJ et al. Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma. Ann Surg Oncol. 2010;17(10):2578鈥?4.View Article PubMed Central PubMed
55.Benz MR et al. FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 2009;15(8):2856鈥?3.View Article PubMed Central PubMed
56.鈥?/div>Eary JF et al. Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome. J Bone Joint Surg. 2014;96(2):152鈥?. A prospective trial found that change in FDG-avidity between baseline and after two cycles of preoperative chemotherapy added prognostic value to patient outcome predictions.View Article PubMed Central PubMed
57.Wong P, et al. Combining targeted agents with modern radiotherapy in soft tissue sarcomas. J Natl Cancer Inst. 2014;106(11).
58.Francis P et al. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics. 2007;8:73.View Article PubMed Central PubMed
59.Rajendran JG et al. [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging. 2003;30(5):695鈥?04.View Article PubMed
60.van der Graaf WT et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012;379(9829):1879鈥?6.View Article PubMed
61.Lee H-J et al. Inhibition of vascular endothelial growth factor A and hypoxia-inducible factor 1伪 maximizes the effects of radiation in sarcoma mouse models through destruction of tumor vasculature. Int J Radiat Oncol Biol Phys. 2015;91(3):621鈥?0.View Article PubMed
62.Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307(5706):58鈥?2.View Article PubMed
63.Sorafenib tosylate, combination chemotherapy, radiation therapy, and surgery in treating patients with high-risk stage IIB-IV soft tissue sarcoma. [cited 2015 March 6]; Available from: https://鈥媍linicaltrials.鈥媑ov/鈥媍t2/鈥媠how/鈥婲CT02050919 . - 作者单位：Lara E. Davis M.D. (1)
Christopher W. Ryan M.D. (1)
1. Oregon Health & Science University, 3181 SW Sam Jackson Park Road, L586, Portland, OR, 97239, USA - 刊物主题：Oncology;
- 出版者：Springer US
- ISSN：1534-6277
文摘